213 related articles for article (PubMed ID: 29274436)
1. Bacillus spore-based oral carriers loading curcumin for the therapy of colon cancer.
Yin L; Meng Z; Zhang Y; Hu K; Chen W; Han K; Wu BY; You R; Li CH; Jin Y; Guan YQ
J Control Release; 2018 Feb; 271():31-44. PubMed ID: 29274436
[TBL] [Abstract][Full Text] [Related]
2. A Novel Folic Acid Receptor-Targeted Drug Delivery System Based on Curcumin-Loaded β-Cyclodextrin Nanoparticles for Cancer Treatment.
Hong W; Guo F; Yu N; Ying S; Lou B; Wu J; Gao Y; Ji X; Wang H; Li A; Wang G; Yang G
Drug Des Devel Ther; 2021; 15():2843-2855. PubMed ID: 34234415
[TBL] [Abstract][Full Text] [Related]
3. Curcumin-polymeric nanoparticles against colon-26 tumor-bearing mice: cytotoxicity, pharmacokinetic and anticancer efficacy studies.
Chaurasia S; Chaubey P; Patel RR; Kumar N; Mishra B
Drug Dev Ind Pharm; 2016; 42(5):694-700. PubMed ID: 26165247
[TBL] [Abstract][Full Text] [Related]
4. A novel folate-modified self-microemulsifying drug delivery system of curcumin for colon targeting.
Zhang L; Zhu W; Yang C; Guo H; Yu A; Ji J; Gao Y; Sun M; Zhai G
Int J Nanomedicine; 2012; 7():151-62. PubMed ID: 22275831
[TBL] [Abstract][Full Text] [Related]
5. Nanodiamond-based multifunctional platform for oral chemo-photothermal combinational therapy of orthotopic colon cancer.
Li Y; Su Y; Pan H; Deng W; Wang J; Liu D; Pan W
Pharmacol Res; 2022 Feb; 176():106080. PubMed ID: 35032663
[TBL] [Abstract][Full Text] [Related]
6. Tumor Targeted Curcumin Delivery by Folate-Modified MPEG-PCL Self-Assembly Micelles for Colorectal Cancer Therapy.
Hu Y; He Y; Ji J; Zheng S; Cheng Y
Int J Nanomedicine; 2020; 15():1239-1252. PubMed ID: 32110020
[TBL] [Abstract][Full Text] [Related]
7. Colon targeted curcumin microspheres laden with ascorbic acid for bioavailability enhancement.
Karade PG; Jadhav NR
J Microencapsul; 2018 Jun; 35(4):372-380. PubMed ID: 30010458
[TBL] [Abstract][Full Text] [Related]
8. Curcumin-guided nanotherapy: a lipid-based nanomedicine for targeted drug delivery in breast cancer therapy.
Lin M; Teng L; Wang Y; Zhang J; Sun X
Drug Deliv; 2016 May; 23(4):1420-5. PubMed ID: 26203688
[TBL] [Abstract][Full Text] [Related]
9. Development of Chitosan-Based pH-Sensitive Polymeric Micelles Containing Curcumin for Colon-Targeted Drug Delivery.
Woraphatphadung T; Sajomsang W; Rojanarata T; Ngawhirunpat T; Tonglairoum P; Opanasopit P
AAPS PharmSciTech; 2018 Apr; 19(3):991-1000. PubMed ID: 29110292
[TBL] [Abstract][Full Text] [Related]
10. In vitro combinatorial anticancer effects of 5-fluorouracil and curcumin loaded N,O-carboxymethyl chitosan nanoparticles toward colon cancer and in vivo pharmacokinetic studies.
Anitha A; Sreeranganathan M; Chennazhi KP; Lakshmanan VK; Jayakumar R
Eur J Pharm Biopharm; 2014 Sep; 88(1):238-51. PubMed ID: 24815764
[TBL] [Abstract][Full Text] [Related]
11. Characteristics and cytotoxicity of folate-modified curcumin-loaded PLA-PEG micellar nano systems with various PLA:PEG ratios.
Phan QT; Le MH; Le TT; Tran TH; Xuan PN; Ha PT
Int J Pharm; 2016 Jun; 507(1-2):32-40. PubMed ID: 27150945
[TBL] [Abstract][Full Text] [Related]
12. Co-delivery of etoposide and curcumin by lipid nanoparticulate drug delivery system for the treatment of gastric tumors.
Jiang H; Geng D; Liu H; Li Z; Cao J
Drug Deliv; 2016 Nov; 23(9):3665-3673. PubMed ID: 27749102
[TBL] [Abstract][Full Text] [Related]
13. Delivery of folic acid-modified liposomal curcumin for targeted cervical carcinoma therapy.
Wang WY; Cao YX; Zhou X; Wei B
Drug Des Devel Ther; 2019; 13():2205-2213. PubMed ID: 31308632
[No Abstract] [Full Text] [Related]
14. Improving intestinal absorption and oral bioavailability of curcumin via taurocholic acid-modified nanostructured lipid carriers.
Tian C; Asghar S; Wu Y; Chen Z; Jin X; Yin L; Huang L; Ping Q; Xiao Y
Int J Nanomedicine; 2017; 12():7897-7911. PubMed ID: 29138557
[TBL] [Abstract][Full Text] [Related]
15. Lipopolysaccharide based oral nanocarriers for the improvement of bioavailability and anticancer efficacy of curcumin.
Chaurasia S; Patel RR; Chaubey P; Kumar N; Khan G; Mishra B
Carbohydr Polym; 2015 Oct; 130():9-17. PubMed ID: 26076595
[TBL] [Abstract][Full Text] [Related]
16. Synergistic effect of the anti-PD-1 antibody with blood stable and reduction sensitive curcumin micelles on colon cancer.
Gong F; Ma JC; Jia J; Li FZ; Wu JL; Wang S; Teng X; Cui ZK
Drug Deliv; 2021 Dec; 28(1):930-942. PubMed ID: 33975498
[TBL] [Abstract][Full Text] [Related]
17. Folate-PEG/Hyd-curcumin/C18-g-PSI micelles for site specific delivery of curcumin to colon cancer cells via Wnt/β-catenin signaling pathway.
Le TT; Kim D
Mater Sci Eng C Mater Biol Appl; 2019 Aug; 101():464-471. PubMed ID: 31029341
[TBL] [Abstract][Full Text] [Related]
18. Novel nanoemulsion based lipid nanosystems for favorable in vitro and in vivo characteristics of curcumin.
Wan K; Sun L; Hu X; Yan Z; Zhang Y; Zhang X; Zhang J
Int J Pharm; 2016 May; 504(1-2):80-8. PubMed ID: 27034002
[TBL] [Abstract][Full Text] [Related]
19. Preparation of curcumin-poly (allyl amine) hydrochloride based nanocapsules: Piperine in nanocapsules accelerates encapsulation and release of curcumin and effectiveness against colon cancer cells.
Slika L; Moubarak A; Borjac J; Baydoun E; Patra D
Mater Sci Eng C Mater Biol Appl; 2020 Apr; 109():110550. PubMed ID: 32228916
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic and anti-colon cancer properties of curcumin-containing chitosan-pectinate composite nanoparticles.
Alkhader E; Roberts CJ; Rosli R; Yuen KH; Seow EK; Lee YZ; Billa N
J Biomater Sci Polym Ed; 2018 Dec; 29(18):2281-2298. PubMed ID: 30376409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
